Molecular Characterization of Carbapenemase-Producing Enterobacterales in Children with Diarrhea in Rural Burkina Faso
Abstract
Background and objective: In recent years, carbapenemase-producing Enterobacterales (CPE) resistance to antibiotics has dramatically increased leading to limitations of their treatment options. In the present study, we investigated the occurrence of carbapenemase-producing Escherichia coli and Salmonella in rural Burkina Faso.
Materials and methods: Salmonella isolates were serotyped according to the Kauffman White scheme. Diarrheagenic Escherichia coli (DEC) strains was identified using 16-plex Polymerase Chain Reaction (PCR), whereas antibiotic susceptibility was realized using the disk diffusion method. Furthermore, multiplex PCR assays were carried out using oligonucleotides to detect the presence of genes of the blaKPC, blaVIM, blaIMP, blaTEM, blaSHV, blaOXA and blaCTX-M types in all E. coli and Salmonella strains.
Results: The study highlighted high resistance rates of the identified bacteria to common antibiotics. Likewise, two strains of E. coli were imipenem resistant with carbapenemase-encoding genes. The genes detected were Klebsiella pneumoniae carbapenemase (KPC), Verona integrin-encoded metallo-β-lactamase (VIM) and Imipenemase (IMP-2) reaching a rate of 40% each in E. coli strains. However, no Salmonella carbapenemases blaKPC, blaVIM or blaIMP were detected.
Conclusion: This study showed that for a real-time infection control and prompt application of antimicrobial chemotherapy, characterization of carbapenemase-producing Enterobacterales in patients is crucial.
Keywords: Antibiotics, Carbapenemase-Producing Enterobacterales, children, Burkina Faso
Keywords:
Antibiotics, Carbapenemase-Producing Enterobacterales, children, Burkina FasoDOI
https://doi.org/10.22270/jddt.v11i1.4513References
World Health Organization (WHO). Antimicrobial resistance; 2018. https://www.who.int/medicines/areas/rational_use/who-amr-amc-report-20181109.pdf
Gauthier L, Dortet L, Cotellon G, Creton E, Cuzon G, et al. Diversity of carbapenemase-producing Escherichia coli isolates, France 2012-2013. Antimicrob Agents Chemother. 2018; 62: pii: e00266-18.
Yousfi M, Touati A, Mairi A, Creton E, Cuzon G, Ponties V, et al. Emergence of Carbapenemase-Producing Escherichia coli Isolated from Companion Animals in Algeria. 2016; Microbial Drug Resist. 22:342-346.
Li XZ, Mehrotra M, Ghimire S, Adewoye L. Beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Vet Microbiol. 2007; 121:197-214.
Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012; 25:682-707.
Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: Here is the storm! Trends Mol Med. 2012; 18:263-272.
Nordmann P, Cornaglia G. Carbapenemase‑producing Enterobacteriaceae: A call for action! Clin Microbiol Infect. 2012; 18:411-412.
Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007; 20:440–458.
Ruppé É, Woerther P-L, Barbier F. Mechanisms of antimicrobial resistance in gram-negative bacilli. Ann Intensive Care 2015; 5 (21) Article 61.
Lowman W, Bamford C, Govind C, Swe Swe Han K, Kularatne R, Senekal M, et al. The SASCM CRE-WG: consensus statement and working guidelines for the screening and laboratory detection of carbapenemase-producing Enterobacteriaceae. South Afr J Infect Dis. 2014; 29:5–11.
Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, et al. Clinical Epidemiology and Molecular Analysis of Extended-Spectrum B-Lactamase-Producing Escherichia coli in Nepal: Characteristics of Sequence Types 131 and 648. Antimicrob Agents Chemother. 2015; 59:3424-32.
Mariappan S, Sekar U, Kamalanathan A. Carbapenemase‑producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes. Int J App Basic Med Res. 2018; 7:32-39.
Ortega A, Saez D, Bautista V, Fernandez-Romero S, Lara N, Aracil B, et al. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48. J Antimicrob Chemother. 2016; 71: 2131-38.
Popoff MY, Bockemuhl J, Gheesling LL. Supplement 2002 (no. 46) to the Kauffmann-White scheme. Res Microbiol. 2004; 155:568-70.
Antikainen J, Tarkka E, Haukka K, Siitonen A, Vaara M, Kirveskari J. New 16 plex PCR method for rapid detection of Diarrheagenic Escherichia coli directly from stool samples. Europ J Clin Microbiol Infect Dis. 2009; 28: 899–908.
Müller D, Greune L, Heusipp G, Karch H, Fruth A, Tschäpe H, et al. Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR. Appl Environ Microbiol. 2007; 73: 3380–90.
Vidal M, Kruger E, Durán C, Lagos R, Levine M, Prado V, et al. Single Multiplex PCR Assay To Identify Simultaneously the Six Categories of Diarrheagenic Escherichia coli Associated with Enteric Infections. J Clin Microbiol. 2005; 43: 5362–65.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Recommandation 2017. Éd. V.1.0 Mars. pp 1-127. https://www.eucast.org/
Moyo SJ, Maselle SY, Matee MI, Langeland N, Mylvaganam H. Identification of Diarrheagenic Escherichia coli isolated from infants and children in Dar es Salaam, Tanzania. BMC Infect Dis. 2007; 7: 92.
Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17:1791-1798.
Mathers AJ, Vegesana K, German-Mesner I, Ainsworth J, Pannone A, Crook DW, et al. Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species. J Hospit Infect. 2020; 104: 456-468.
Hossain MZ, Naher A, Hasan P, Mozazfia KT, Tasnim H, Ferdush Z, et al. Prevalent bacteria and their sensitivity and resistance pattern to antibiotics: a study in Dhaka medical college hospital. J Dhaka Med Coll. 2017; 26: 52-64.
Halat DH, Moubareck CA. The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics 2020; 9, 186.
Nisha KV, Veena SA, Rathika SD, Vijaya SM, Avinash SK. Antimicrobial susceptibility, risk factors and prevalence of bla cefotaximase, temoneira, and sulfhydryl variable genes among Escherichia coli in community-acquired pediatric urinary tract infection. J Lab Physic. 2017; 9:156-62.
Devi LS, Broor S, Rautela RS, Grover SS, Chakravarti A, Chattopadhya D. Increasing Prevalence of Escherichia coli and Klebsiella pneumoniae Producing CTX-M-Type Extended‑Spectrum Beta‑Lactamase, Carbapenemase, and NDM-1 in Patients from a Rural Community with Community Acquired Infections: A 3‑Year Study. Int J App Basic Med Res. 2020; 10:156-163.
Jean S-S, Lee W-S, Lam C, Hsu C-W, Chen R-J, Hsueh P-R. Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options. Future Microbiol. 2015; 10: 407–425.
Day MR, Meunier D, Doumith M, de Pinna E, Woodford N, Hopkins KL. Carbapenemase-producing Salmonella enterica isolates in the UK. J Antimicrob Chemother. 2015; 2165-2167.
Le Hello S, Bekhit A, Granier SA, Barua H, Beutlich J, Zajac M, et al. The global establishment of a highly-fluoroquinolone resistant Salmonella enterica serotype Kentucky ST198 strain. Front Microbiol. 2013; 4: 395.
Bougnom BP, Zongo C, McNally A, Ricci V, Etoa FX, Thiele-Bruhn S, et al. Wastewater used for urban agriculture in West Africa as a reservoir for antibacterial resistance dissemination. Environ Res. 2019; 168:14-24.
Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009; 9:228–236.
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013; 13: 785–796.
Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, et al. Worldwide diversity of Klebsiella pneumoniae that produce β-lactamase blaKPC-2 gene. Emerg Infect Dis. 2010; 16:1349–56.
Walsh TR, Toleman MA, Poirel L, Nordmannn P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005; 18:306–325.
Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013; 68: 487–9.
Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J, European NDM-1 Survey Participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill. 2010; 15:pii19716.
https://www.eurosurveillance.org/images/dynamic/EE/V15N46/art19716.pdf
Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem‑resistant Enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis. 2011; 53:60‑67.
Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, et al. Clinical epidemiology of carbapenem‑intermediate or ‑resistant Enterobacteriaceae. J Antimicrob Chemother. 2011; 66:1600‑08.
Swaminathan M, Sharma S, Poliansky Blash S, Patel G, Banach DB, Phillips M, et al. Prevalence and risk factors for acquisition of carbapenem‑resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol. 2013; 34:809‑817.
Ling ML, Tee YM, Tan SG, Amin IM, How KB, Tan KY, et al. Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control. 2015; 4:26.
Borer A, Saidel‑Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, et al. Attributable mortality rate for carbapenem‑resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009; 30:972‑6.
Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase‑producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009; 30:1180‑85.
Teo J, Cai Y, Tang S, Lee W, Tan TY, Tan TT, et al. Risk factors, molecular epidemiology and outcomes of ertapenem‑resistant, carbapenem‑susceptible Enterobacteriaceae: A case‑case‑control study. PLoS One 2012; 7:e34254.
Bleumin D, Cohen MJ, Moranne O, Esnault VL, Benenson S, Paltiel O, et al. Carbapenem‑resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. J Infect. 2012; 65:318‑25.
Birgy A, Doit C, Mariani-Kurkdjian P, Gene N, Faye A, Arlet G, et al. Early Detection of Colonization by VIM-1-Producing Klebsiella pneumoniae and NDM-1-Producing Escherichia coli in Two Children Returning to France. J Clin Microbiol. 2011; 49: 3085–87.
Overturf GD. Carbapenemases: a brief review for pediatric infectious disease specialists. Pediatr Infect Dis J. 2010; 29:68–70.
Cavaco LM, Hansen F, Mushtaq S, Hill RLR, Woodford N, Le Hello S, et al. Evaluation of temocillin for phenotypic carbapenemase screening of Escherichia coli and Salmonella enterica isolates in relation to the presence of genes encoding ESBLs and carbapenemase production. J Antimicrob Chemother. 2019; 74:639-644.
Published
Abstract Display: 702 
PDF Downloads: 855 PDF Downloads: 904 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.